Literature DB >> 1081418

Editorial: After type B hepatitis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1081418      PMCID： PMC1675197     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  15 in total

1.  Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis.

Authors:  W D Reed; A L Eddleston; H Cullens; R Williams; A J Zuckerman; D K Peters; D G Williams; W A Maycock
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

2.  Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations.

Authors:  C E Cherubin; R H Purcell; J J Lander; T G McGinn; L A Cone
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

3.  Cytoplasmic localisation of Australia antigen in the liver.

Authors:  S Hadziyannis; A Moussouros; C Vissoulis; A Afroudakis
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

4.  Lymphocyte transformation by Australia antigen.

Authors:  A A Laiwah
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

Review 5.  Immune response in acute viral hepatitis.

Authors:  P A Berg
Journal:  Clin Gastroenterol       Date:  1974-05

6.  Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention.

Authors:  S Krugman; J P Giles
Journal:  N Engl J Med       Date:  1973-04-12       Impact factor: 91.245

7.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

Review 8.  Immunopathology of viral hepatitis in man.

Authors:  W D Reed; A L Eddleston; R Williams
Journal:  Prog Med Virol       Date:  1974

9.  Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.

Authors:  J Desmyter; A F Bradburne; C Vermylen; R Daneels; J Boelaert
Journal:  Lancet       Date:  1975-08-30       Impact factor: 79.321

10.  Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.

Authors:  G C de Gast; B Houwen; H O Nieweg
Journal:  Br Med J       Date:  1973-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.